dextroamphetamine has been researched along with Craniopharyngioma in 2 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Craniopharyngioma: A benign pituitary-region neoplasm that originates from Rathke's pouch. The two major histologic and clinical subtypes are adamantinous (or classical) craniopharyngioma and papillary craniopharyngioma. The adamantinous form presents in children and adolescents as an expanding cystic lesion in the pituitary region. The cystic cavity is filled with a black viscous substance and histologically the tumor is composed of adamantinomatous epithelium and areas of calcification and necrosis. Papillary craniopharyngiomas occur in adults, and histologically feature a squamous epithelium with papillations. (From Joynt, Clinical Neurology, 1998, Ch14, p50)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine the use of the central nervous system stimulant dextroamphetamine sulfate to regulate appetite and subsequent weight gain in children treated for craniopharyngioma." | 9.10 | The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. ( Krawiecki, N; Mason, PW; Meacham, LR, 2002) |
| "To examine the use of the central nervous system stimulant dextroamphetamine sulfate to regulate appetite and subsequent weight gain in children treated for craniopharyngioma." | 5.10 | The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. ( Krawiecki, N; Mason, PW; Meacham, LR, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mason, PW | 1 |
| Krawiecki, N | 1 |
| Meacham, LR | 1 |
| Ismail, D | 1 |
| O'Connell, MA | 1 |
| Zacharin, MR | 1 |
1 trial available for dextroamphetamine and Craniopharyngioma
| Article | Year |
|---|---|
The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma.
Topics: Analysis of Variance; Body Mass Index; Central Nervous System Stimulants; Child; Child Behavior Diso | 2002 |
1 other study available for dextroamphetamine and Craniopharyngioma
| Article | Year |
|---|---|
Dexamphetamine use for management of obesity and hypersomnolence following hypothalamic injury.
Topics: Adolescent; Central Nervous System Stimulants; Child; Child, Preschool; Craniopharyngioma; Dextroamp | 2006 |